About the Journal

The Biologic Orthopedics Journal (BOJ) is a peer-reviewed, open-access scholarly journal and the official publication of the Interventional Orthobiologics Foundation (IOF). BOJ publishes original research, reviews, and scholarly commentary focused on biologic therapies across the continuum of orthopedic care.

The journal covers established biologic treatments—including bone marrow aspirate, platelet-rich plasma, and adult stem cells—as well as emerging biologics, technologies, and innovative clinical techniques. BOJ provides clinicians, researchers, and scientists with evidence-based information to support safe, ethical, and effective integration of biologic therapies into orthopedic practice.

IOF is a 501(c)(3) nonprofit organization dedicated to advancing evidence-based orthobiologic medicine through education, research, and professional development. IOF supports BOJ’s mission by promoting scientific rigor, transparency, and responsible clinical application of regenerative therapies.

Focus & Scope

The Biologic Orthopedics Journal aims to advance knowledge and best practices in biologic orthopedics by publishing high-quality, peer-reviewed research and analysis that emphasize patient safety, clinical efficacy, and ethical standards.

The journal seeks to:

  • Promote evidence-based science and research in biologic orthopedics
  • Support the development and dissemination of safe, effective, and ethical clinical practices
  • Provide an international platform for researchers, scientists, and clinicians
  • Encourage transparency, reproducibility, and scientific integrity

Vision

BOJ envisions a global community of researchers, scientists, and practitioners who are empowered to apply biologic orthopedics responsibly, advancing patient care and improving healthcare outcomes worldwide.

While regenerative medicine has demonstrated significant potential to improve health outcomes and provide economic benefits to healthcare systems, biologic orthopedics continues to face challenges related to standardization, policy development, and evidence-based validation. BOJ seeks to address these challenges by fostering rigorous scholarship and open scientific discourse.

Open Access Policy

The Biologic Orthopedics Journal is a fully open-access journal, providing immediate and permanent free access to all published content. Readers may read, download, copy, distribute, and use articles for non-commercial purposes without restriction, provided proper attribution is given.

Copyright & Licensing

All articles published in BOJ are licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY-NC 4.0).

Copyright of published articles is retained by the author(s). Authors grant Dougmar Publishing Group Inc. (DPG) the right to publish the work and to identify itself as the original publisher. Authors also grant DPG exclusive commercial rights. Non-commercial third parties may use the content freely, provided appropriate attribution and citation are included.

Peer Review Process

All submissions undergo a double-blind peer review process.

  1. Initial Quality Control
    Submissions are first reviewed in-house for completeness, ethical compliance, competing interests, financial disclosures, plagiarism, and adherence to journal policies.
  2. Editorial Assessment
    The Editor evaluates submissions for relevance, scientific quality, and alignment with the journal’s scope. Manuscripts may be declined at this stage.
  3. Peer Review
    Manuscripts accepted for review are evaluated by independent reviewers with subject-matter expertise. Reviewer identities are concealed from authors, and author identities are concealed from reviewers.
  4. Revision and Decision
    Reviewer comments are assessed by the Editor and shared with authors for revision. Final publication decisions are made solely on scholarly merit.

Submissions authored by the Editor are handled by the Co-Editors and follow the same blinded review process to ensure editorial independence.

Editorial Independence

Editorial decisions are made independently of the publisher and the Interventional Orthobiologics Foundation. Publication decisions are based exclusively on scientific quality, ethical standards, and relevance to the journal’s scope.

Article Processing Charges (APC)

BOJ does not charge submission fees.

An Article Processing Charge (APC) of USD $975 applies only to non-member authors. Authors who are members in good standing of the IOF are exempt from APCs. Letters to the Editor, short commentaries, and select invited articles are also exempt.

APCs support:

  • Rigorous peer review
  • Professional editorial and production services
  • DOI assignment via Crossref
  • Long-term digital preservation

An author’s ability to pay APCs does not influence editorial decisions.

Authors residing in countries classified by the United Nations as Least Developed Countries (LDCs) may request a full waiver. Authors in other countries who are unable to pay may be eligible for a reduced APC. Requests should be made prior to or during submission by contacting the publisher at jbirkby@dougmargroup.com.

Archiving & Preservation

All BOJ content is preserved through Portico, ensuring long-term digital archiving and accessibility.

Publication Frequency & Format

Articles are published on a continuous publication model and made available in both HTML (web) and PDF formats. BOJ aims to publish accepted manuscripts within approximately 60 days, subject to reviewer and author response times.